A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.
收藏DataCite Commons2025-10-17 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004445/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will compare progression-free survival in patients with advanced non-squamous non-small cell lung cancer. Patients who do not progress following 4 cycles of induction treatment with pemetrexed and cisplatin will be randomized 2:1 to receive either maintenance pemetrexed or placebo.
提供机构：
Vivli
创建时间：
2019-09-09
